Pharma, Metals Outperform As IT Faces AI Pressure: IME Capital

In an interview with ET NOW, Ashi Anand, Founder & CEO of IME Capital, discussed the current market environment amid geopolitical uncertainty, rising oil prices, and sector-specific shifts. Ashi highlighted pharma as a defensive growth opportunity supported by GLP-1 drugs and noted that metals are benefiting from the global AI infrastructure buildout. He also explained that IT services stocks remain under pressure as markets assess the long-term impact of AI-driven productivity gains on pricing, margins, and future earnings growth.